[BrokerRatings]Analyst Ratings Update: Biotech and Large-Cap Momentum Amidst Selective Downgrades

Biotechnology and diverse large-cap names lead with multiple strong buy ratings over the past three days. Notable upgrades include NVO, IQV, CRL, BA, ASML, and TRI. Real Estate (REITs) also saw several new strong buys on Monday. Average target price upsides suggest continued momentum. However, downgrades for GOOG, LULU, and new strong sells for NFE and DUOL signal caution in specific tech and energy segments.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Scroll to Top